RxDoctor Payments Data

Arvind Trindade, MD

Gastroenterology · New Brunswick, NJNPI 1699934075

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Pentax Of America, Inc. at 25.4% of the total. Reporting peaked in 2022 at $31,495 and has fallen 77.9% since, to $6,954 in 2025. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,801in general payments, 2019–2025

Across 150 payments — averaging $545.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pentax Of America, Inc.$21K
  • Boston Scientific$20K
  • Lucid Diagnostics Inc.$13K
  • Exact Sciences$12K
  • Creo Medical Inc.$7K
  • Gyrus ACMI, Inc.$5K
  • plus $3K from 8 others
$570,689in research payments, 2019–2025

Across 61 payments — averaging $9355.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lucid Diagnostics Inc.$135K
  • Pentax Of America, Inc.$129K
  • Erbe Elektromedizin GmbH$103K
  • Olympus Corporation Of The Americas$79K
  • Medtronic$77K
  • Ninepoint Medical, Inc.$26K
  • plus $23K from 1 others

What the payments were for

  • Consulting fees$47,34158%
  • Speaking & faculty fees$14,27117%
  • Travel & lodging$13,10216%
  • Food & beverage$7,0879%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,801 in reported general payments places this provider in the 95th percentile of 701 gastroenterology providers in New Jersey.

See all gastroenterology providers in New Jersey

Medicare billing

Part B allowed, 2024
$105,342
Medicare patients
248
Services billed
690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole35$704
Sucralfate14$629

Paid to pharmacies, not to this prescriber.

Other gastroenterology in New Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →